Policy Alerts

340B Drug Pricing Program

HRSA its long-awaited proposed 340B Drug Pricing Program “Mega Guidance,” in the form of a notice with a 60-day comment period. The notice includes the following key areas on which HRSA is either providing further clarification or seeking modifications: hospital eligibility; Group Purchasing Organization prohibition; patient definition; duplicate discounts; contract pharmacy; and hospital audits. The guidance also proposes enhanced program integrity requirements for pharmaceutical manufacturers participating in the 340B program.

Click here for AHA Bulletin on the new requirements.

ASHNHA sends out policy alerts to members  as needed.  Previous policy alerts are listed below.

Medicaid Presumptive Eligibility – October 31, 2013

EHR Incentive Program – October 21, 2013

Two Midnight Rule – October 8, 2013

2014 Final Medicare Payment Rule Highlights – September 6, 2013

Critical Access Hospital Revised Operations Manual – August 22, 2013

Health Insurance Marketplace Training: Becoming a Certified Application Counselor Organization – July 31, 2013

IRS Approved Delays and Changes to Play or Pay – July 12, 2013